227 related articles for article (PubMed ID: 27397758)
21. In vitro evaluation of the catalytic activity of paraoxonases and phosphotriesterases predicts the enzyme circulatory levels required for in vivo protection against organophosphate intoxications.
Ashani Y; Leader H; Aggarwal N; Silman I; Worek F; Sussman JL; Goldsmith M
Chem Biol Interact; 2016 Nov; 259(Pt B):252-256. PubMed ID: 27163850
[TBL] [Abstract][Full Text] [Related]
22. The potential role of bioscavenger in the medical management of nerve-agent poisoned casualties.
Rice H; Mann TM; Armstrong SJ; Price ME; Green AC; Tattersall JEH
Chem Biol Interact; 2016 Nov; 259(Pt B):175-181. PubMed ID: 27144491
[TBL] [Abstract][Full Text] [Related]
23. Optimization of the Ocular Treatment Following Organophosphate Nerve Agent Insult.
Egoz I; Nili U; Grauer E; Gore A
Toxicol Sci; 2017 Sep; 159(1):50-63. PubMed ID: 28903494
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous Time-concentration Analysis of Soman and VX Adducts to Butyrylcholinesterase and Albumin by LC-MS-MS.
Lee JY; Kim C; Lee YH
J Anal Toxicol; 2018 Jun; 42(5):293-299. PubMed ID: 29618078
[TBL] [Abstract][Full Text] [Related]
25. Variants of Phosphotriesterase for the Enhanced Detoxification of the Chemical Warfare Agent VR.
Bigley AN; Mabanglo MF; Harvey SP; Raushel FM
Biochemistry; 2015 Sep; 54(35):5502-12. PubMed ID: 26274608
[TBL] [Abstract][Full Text] [Related]
26. Galantamine is a novel post-exposure therapeutic against lethal VX challenge.
Hilmas CJ; Poole MJ; Finneran K; Clark MG; Williams PT
Toxicol Appl Pharmacol; 2009 Oct; 240(2):166-73. PubMed ID: 19647007
[TBL] [Abstract][Full Text] [Related]
27. Enzymes for the homeland defense: optimizing phosphotriesterase for the hydrolysis of organophosphate nerve agents.
Tsai PC; Fox N; Bigley AN; Harvey SP; Barondeau DP; Raushel FM
Biochemistry; 2012 Aug; 51(32):6463-75. PubMed ID: 22809162
[TBL] [Abstract][Full Text] [Related]
28. Percutaneous exposure to the nerve agent VX: Efficacy of combined atropine, obidoxime and diazepam treatment.
Joosen MJ; van der Schans MJ; van Helden HP
Chem Biol Interact; 2010 Oct; 188(1):255-63. PubMed ID: 20599844
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of the bone injection gun in the treatment of organophosphate poisoning.
Eisenkraft A; Gilat E; Chapman S; Baranes S; Egoz I; Levy A
Biopharm Drug Dispos; 2007 Apr; 28(3):145-50. PubMed ID: 17315239
[TBL] [Abstract][Full Text] [Related]
30. QM/MM and MM MD simulations on decontamination of the V-type nerve agent VX by phosphotriesterase: toward a comprehensive understanding of steroselectivity and activity.
Fan F; Zheng Y; Fu Y; Zhang Y; Zheng H; Lyu C; Chen L; Huang J; Cao Z
Phys Chem Chem Phys; 2022 May; 24(18):10933-10943. PubMed ID: 35466335
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of a substituted β-cyclodextrin to prevent cyclosarin toxicity in vivo.
Worek F; Seeger T; Zengerle M; Kubik S; Thiermann H; Wille T
Toxicol Lett; 2014 Apr; 226(2):222-7. PubMed ID: 24561299
[TBL] [Abstract][Full Text] [Related]
32. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning.
Antonijevic B; Stojiljkovic MP
Clin Med Res; 2007 Mar; 5(1):71-82. PubMed ID: 17456837
[TBL] [Abstract][Full Text] [Related]
33. Toxicity of an acute dose of agent VX and other organophosphorus esters in the chicken.
Wilson BW; Henderson JD; Chow E; Schreider J; Goldman M; Culbertson R; Dacre JC
J Toxicol Environ Health; 1988; 23(1):103-13. PubMed ID: 3336055
[TBL] [Abstract][Full Text] [Related]
34. The influence of inhibitors and other factors on cholinesterases.
Bajgar J
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1991; 34(1):5-77. PubMed ID: 1759111
[TBL] [Abstract][Full Text] [Related]
35. In vivo microdialysis and electroencephalographic activity in freely moving guinea pigs exposed to organophosphorus nerve agents sarin and VX: analysis of acetylcholine and glutamate.
O'Donnell JC; McDonough JH; Shih TM
Arch Toxicol; 2011 Dec; 85(12):1607-16. PubMed ID: 21695469
[TBL] [Abstract][Full Text] [Related]
36. Application of kinetic-based computer modelling to evaluate the efficacy of HI 6 in percutaneous VX poisoning.
Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F
Toxicology; 2006 Jul; 224(1-2):74-80. PubMed ID: 16740352
[TBL] [Abstract][Full Text] [Related]
37. Enzymatic neutralization of the chemical warfare agent VX: evolution of phosphotriesterase for phosphorothiolate hydrolysis.
Bigley AN; Xu C; Henderson TJ; Harvey SP; Raushel FM
J Am Chem Soc; 2013 Jul; 135(28):10426-32. PubMed ID: 23789980
[TBL] [Abstract][Full Text] [Related]
38. Post-exposure therapy with recombinant human BuChE following percutaneous VX challenge in guinea-pigs.
Mumford H; Troyer JK
Toxicol Lett; 2011 Sep; 206(1):29-34. PubMed ID: 21620937
[TBL] [Abstract][Full Text] [Related]
39. [The VR, the Russian version of the nerve agent VX].
Cuquel AC; Dorandeu F; Ceppa F; Renard C; Burnat P
Ann Pharm Fr; 2015 May; 73(3):180-9. PubMed ID: 25592653
[TBL] [Abstract][Full Text] [Related]
40. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 1: guinea pigs challenged with VX.
Braue EH; Smith KH; Doxzon BF; Lumpkin HL; Clarkson ED
Cutan Ocul Toxicol; 2011 Mar; 30(1):15-28. PubMed ID: 20942572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
